Public company
LENZ Therapeutics, Inc.
LENZCIK 0001815776
Price$3.50
1 year-83.7%
Disclosed transactions14
Buys / sells6 / 2
Max Insider Score57
Connections with evidence10
LENZ · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 57 | Schimmelpennink Evert B.Director, President, CEO and Secretary | LENZLENZ Therapeutics, Inc. Open-market purchase | BUY | $251K 28.1K sh |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Holds over 5% ofevidenceFMR LLC2% of class · Schedule 13G · Nov 4, 2026
- ← Holds over 5% ofevidenceBraden M Leonard6.7% of class · Schedule 13G · Nov 3, 2026
- ← Holds over 5% ofevidenceRA Capital Management, L.P.0.2% of class · Schedule 13D · Nov 1, 2026
- ← Insider ofevidence